Tmod3 Phosphorylation Mediates AMPK-Dependent GLUT4 Plasma Membrane Insertion in Myoblasts.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 14 01 2021
accepted: 22 03 2021
entrez: 7 5 2021
pubmed: 8 5 2021
medline: 22 12 2021
Statut: epublish

Résumé

Insulin and muscle contractions mediate glucose transporter 4 (GLUT4) translocation and insertion into the plasma membrane (PM) for glucose uptake in skeletal muscles. Muscle contraction results in AMPK activation, which promotes GLUT4 translocation and PM insertion. However, little is known regarding AMPK effectors that directly regulate GLUT4 translocation. We aim to identify novel AMPK effectors in the regulation of GLUT4 translocation. We performed biochemical, molecular biology and fluorescent microscopy imaging experiments using gain- and loss-of-function mutants of tropomodulin 3 (Tmod3). Here we report Tmod3, an actin filament capping protein, as a novel AMPK substrate and an essential mediator of AMPK-dependent GLUT4 translocation and glucose uptake in myoblasts. Furthermore, Tmod3 plays a key role in AMPK-induced F-actin remodeling and GLUT4 insertion into the PM. Our study defines Tmod3 as a key AMPK effector in the regulation of GLUT4 insertion into the PM and glucose uptake in muscle cells, and offers new mechanistic insights into the regulation of glucose homeostasis.

Identifiants

pubmed: 33959097
doi: 10.3389/fendo.2021.653557
pmc: PMC8095187
doi:

Substances chimiques

Actins 0
Glucose Transporter Type 4 0
Insulin 0
Slc2a4 protein, mouse 0
Tmod3 protein, mouse 0
Tropomodulin 0
AMP-Activated Protein Kinases EC 2.7.11.31
Glutathione GAN16C9B8O
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

653557

Informations de copyright

Copyright © 2021 Shrestha, Lim, Bi, Robinson and Han.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Biol Chem. 1999 Apr 9;274(15):10071-8
pubmed: 10187787
J Biol Chem. 2003 Oct 10;278(41):40000-9
pubmed: 12860976
Biochemistry. 2005 Mar 29;44(12):4905-10
pubmed: 15779917
Cell Signal. 2011 Oct;23(10):1546-54
pubmed: 21683139
J Biol Chem. 2011 Jan 21;286(3):2194-204
pubmed: 21078668
Diabetes. 2003 May;52(5):1066-72
pubmed: 12716734
J Biol Chem. 2004 Sep 24;279(39):40699-706
pubmed: 15247264
J Biol Chem. 2006 Nov 24;281(47):36454-65
pubmed: 17012745
Am J Physiol. 1997 Dec;273(6):E1039-51
pubmed: 9435517
J Biol Chem. 2003 Apr 25;278(17):14599-602
pubmed: 12637568
Life Sci. 2008 Mar 12;82(11-12):615-22
pubmed: 18262572
Biochemistry. 2006 Oct 3;45(39):12068-75
pubmed: 17002306
Circ Res. 2007 Feb 16;100(3):328-41
pubmed: 17307971
IUBMB Life. 2009 Jan;61(1):18-26
pubmed: 18798311
Mol Endocrinol. 2004 Feb;18(2):359-72
pubmed: 14615606
Physiol Rev. 2013 Jul;93(3):993-1017
pubmed: 23899560
Mol Endocrinol. 1997 Dec;11(13):1881-90
pubmed: 9415393
Am J Physiol. 1999 May;276(5):E938-44
pubmed: 10329989
J Cell Sci. 2004 Dec 1;117(Pt 25):5985-93
pubmed: 15546921
Diabetes. 2006 Jul;55(7):2051-8
pubmed: 16804075
J Physiol. 2009 Jul 1;587(Pt 13):3363-73
pubmed: 19403598
Diabetes. 2017 Jun;66(6):1548-1559
pubmed: 28389470
Pflugers Arch. 2006 Mar;451(6):803-13
pubmed: 16244881
Sci Rep. 2016 Jul 04;6:29204
pubmed: 27374327
Physiol Rev. 2008 Jan;88(1):1-35
pubmed: 18195081
Physiology (Bethesda). 2005 Aug;20:260-70
pubmed: 16024514
J Cell Biol. 2005 Mar 14;168(6):921-8
pubmed: 15753124
FASEB J. 2010 Jul;24(7):2254-61
pubmed: 20203090
J Biol Chem. 1983 May 25;258(10):6636-44
pubmed: 6133866
J Physiol. 2015 Feb 1;593(3):645-56
pubmed: 25416624
J Cell Sci. 2000 Jan;113 Pt 2:279-90
pubmed: 10633079
Am J Physiol Endocrinol Metab. 2002 May;282(5):E1008-13
pubmed: 11934664
Am J Physiol. 1999 Oct;277(4):E733-41
pubmed: 10516134
Diabetes. 1998 Aug;47(8):1369-73
pubmed: 9703344
J Cell Biol. 2010 Apr 5;189(1):95-109
pubmed: 20368620
Dev Cell. 2012 Jun 12;22(6):1286-98
pubmed: 22609160
Mol Ther. 2004 Feb;9(2):209-17
pubmed: 14759805
J Biol Chem. 2001 Apr 6;276(14):10677-82
pubmed: 11145966
Exp Cell Res. 2011 Feb 1;317(3):249-61
pubmed: 21036167
Biol Cell. 2008 Nov;100(11):645-57
pubmed: 18482007
Methods Mol Biol. 2008;433:287-299
pubmed: 18679631
Nat Commun. 2015 Jan 09;6:5951
pubmed: 25575350
J Clin Invest. 2006 Jul;116(7):1767-75
pubmed: 16823474
J Cell Biol. 2003 Apr 28;161(2):371-80
pubmed: 12707310
Exp Physiol. 2014 Dec 1;99(12):1574-80
pubmed: 25239922
Mol Endocrinol. 2008 Dec;22(12):2703-15
pubmed: 18801932
Trends Cell Biol. 2005 Jun;15(6):333-41
pubmed: 15953552
Mol Cell Biol. 2007 Jul;27(14):5172-83
pubmed: 17515613
Cytoskeleton (Hoboken). 2012 Jun;69(6):337-70
pubmed: 22488942
J Biol Chem. 2010 Jan 15;285(3):1653-60
pubmed: 19915010
J Biol Chem. 2010 Oct 22;285(43):33265-33280
pubmed: 20650902
J Biol Chem. 1998 May 8;273(19):11937-43
pubmed: 9565622
Diabetes. 2004 Feb;53(2):330-5
pubmed: 14747282
Am J Physiol. 1997 Dec;273(6):E1107-12
pubmed: 9435525
Am J Physiol Endocrinol Metab. 2001 May;280(5):E677-84
pubmed: 11287349
J Cell Sci. 2005 Feb 15;118(Pt 4):651-4
pubmed: 15701920
Mol Cell Biol. 1999 Jun;19(6):4008-18
pubmed: 10330141
FEBS Lett. 1998 May 8;427(2):193-7
pubmed: 9607310
Mol Biol Cell. 2003 Mar;14(3):1002-16
pubmed: 12631719
Diabetes. 1999 Aug;48(8):1667-71
pubmed: 10426389
Diabetologia. 2015 Jan;58(1):19-30
pubmed: 25280670
Cell Rep. 2015 Feb 24;10(7):1055-65
pubmed: 25704810
Nat Med. 2002 Nov;8(11):1288-95
pubmed: 12368907
J Physiol. 2016 Sep 1;594(17):4997-5008
pubmed: 27061726
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5817-21
pubmed: 7597034
J Biol Chem. 1996 Dec 6;271(49):31372-8
pubmed: 8940145
Cell Metab. 2011 Sep 7;14(3):378-89
pubmed: 21907143
Mol Metab. 2014 Jul 28;3(7):742-53
pubmed: 25353002
Diabetes. 1999 May;48(5):1192-7
pubmed: 10331428
Biophys J. 2002 Nov;83(5):2716-25
pubmed: 12414704
Biophys J. 2005 Jan;88(1):372-83
pubmed: 15475586
Mol Cell. 2001 May;7(5):1085-94
pubmed: 11389854
Cell Metab. 2005 Jan;1(1):15-25
pubmed: 16054041
FEBS J. 2016 Aug;283(16):2987-3001
pubmed: 26934201
Nat Methods. 2008 Jul;5(7):605-7
pubmed: 18536722
Diabetes. 2013 Apr;62(4):1139-51
pubmed: 23274900
Mol Biol Cell. 2006 Oct;17(10):4484-93
pubmed: 16914513

Auteurs

Man Mohan Shrestha (MM)

Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.

Chun-Yan Lim (CY)

Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.

Xuezhi Bi (X)

Bioprocessing Technology Institute, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.

Robert C Robinson (RC)

Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.

Weiping Han (W)

Laboratory of Metabolic Medicine, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH